De enige veilige en legale route is via een arts
it is proven
While real-world data on the level of adherence to dual GLP1-RA/GIP agonists are not available to date, some considerations can be drawn from available clinical trials and experiences with other pharmacological classes
We start with the patient: weight history, prior attempts, family history, blood pressure, glucose, cholesterol, liver markers, sleep, medications, mental health, alcohol use, menopause or PMOS context when relevant, and what the patient is actually trying to accomplish
And do not worry, the process is void anonymous
At Mousai Wellness Center, no therapeutic protocol is recommended without a comprehensive review of each patients health history, current metabolic status, and individual risk profile